Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

Clinical trial NCT05836220 · COMPLETED

Trial details

NCT number: NCT05836220
Sponsor: Pathalys Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism End Stage Kidney Disease

Start date: 2023-05-15
Primary completion: 2025-08-05
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.